Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · IEX Real-Time Price · USD
3.76
+0.03 (0.80%)
Aug 8, 2022 4:00 PM EDT - Market closed
Cash Flow Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Net Income
|
-125.6 | -67.25 | -35.26 | -8.93 | -4.6 |
| Depreciation & Amortization
|
0.21 | 0.05 | 0.05 | 0.04 | 0.02 |
| Share-Based Compensation
|
14.04 | 7.77 | 3.64 | 0.06 | 0.01 |
| Other Operating Activities
|
11.21 | 7.29 | 6.89 | 0.37 | 2.22 |
| Operating Cash Flow
|
-100.15 | -52.15 | -24.67 | -8.45 | -2.35 |
| Capital Expenditures
|
-2.71 | -0.14 | -0.02 | -0.08 | -0.08 |
| Change in Investments
|
133.32 | -281.55 | 0 | 0 | 0 |
| Investing Cash Flow
|
130.61 | -281.69 | -0.02 | -0.08 | -0.08 |
| Share Issuance / Repurchase
|
0.73 | 214.94 | 0 | 0 | 0.1 |
| Debt Issued / Paid
|
0 | 0 | 0 | 0 | -0.05 |
| Other Financing Activities
|
0 | 0 | 127.76 | 52.31 | 9.92 |
| Financing Cash Flow
|
0.73 | 214.94 | 127.76 | 52.31 | 9.97 |
| Net Cash Flow
|
31.19 | -118.89 | 103.06 | 43.78 | 7.55 |
| Free Cash Flow
|
-102.86 | -52.29 | -24.7 | -8.53 | -2.43 |
| Free Cash Flow Per Share
|
-2.84 | -1.59 | -11.90 | -4.23 | -1.26 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).